デフォルト表紙
市場調査レポート
商品コード
1124265

世界のトゥレット症候群治療市場:考察と予測 (2028年まで)

Global Tourette Syndrome Treatment Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 118 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界のトゥレット症候群治療市場:考察と予測 (2028年まで)
出版日: 2022年09月12日
発行: QYResearch
ページ情報: 英文 118 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、トゥレット症候群治療 (Tourette Syndrome Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界のトゥレット症候群治療の市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Antipsychotics
    • Non Antipsychotics
  • 市場:アプリケーション別
    • 世界のトゥレット症候群治療の市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • Children
    • Adult
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のトゥレット症候群治療の市場展望 (2017-2028)
  • トゥレット症候群治療の市場成長トレンド:地域別
    • トゥレット症候群治療 市場規模:地域別: 2017 VS 2021 VS 2028
    • トゥレット症候群治療の市場規模実績:地域別 (2017-2022)
    • トゥレット症候群治療の市場規模予測:地域別 (2023-2028)
  • トゥレット症候群治療 市場動向
    • トゥレット症候群治療 業界動向
    • トゥレット症候群治療 市場の促進要因
    • トゥレット症候群治療 市場の課題
    • トゥレット症候群治療 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界のトゥレット症候群治療の上位企業:収益別
    • 世界のトゥレット症候群治療の上位企業:収益別 (2017-2022)
    • 世界のトゥレット症候群治療の収益シェア:企業別 (2017-2022)
  • 世界のトゥレット症候群治療の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング:トゥレット症候群治療の収益
  • 世界のトゥレット症候群治療 市場集中度
    • 世界のトゥレット症候群治療 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: トゥレット症候群治療の収益 2021
  • トゥレット症候群治療の主要企業の本社および事業エリア
  • 主要企業 トゥレット症候群治療の製品ソリューションおよびサービス
  • 市場参入時期: トゥレット症候群治療 市場
  • M&A, 拡張計画

第4章 トゥレット症候群治療 内訳データ:タイプ別

  • 世界のトゥレット症候群治療の市場規模実績:タイプ別 (2017-2022)
  • 世界のトゥレット症候群治療の市場規模予測:タイプ別 (2023-2028)

第5章 トゥレット症候群治療 内訳データ:アプリケーション別

  • 世界のトゥレット症候群治療の市場規模実績:アプリケーション別 (2017-2022)
  • 世界のトゥレット症候群治療の市場規模予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米のトゥレット症候群治療 市場規模 (2017-2028)
  • 北米のトゥレット症候群治療 市場規模:タイプ別
    • 北米のトゥレット症候群治療 市場規模:タイプ別 (2017-2022)
    • 北米のトゥレット症候群治療 市場規模:タイプ別 (2023-2028)
    • 北米のトゥレット症候群治療の市場シェア:タイプ別 (2017-2028)
  • 北米のトゥレット症候群治療 市場規模:アプリケーション別
    • 北米のトゥレット症候群治療 市場規模:アプリケーション別 (2017-2022)
    • 北米のトゥレット症候群治療 市場規模:アプリケーション別 (2023-2028)
    • 北米のトゥレット症候群治療の市場シェア:アプリケーション別 (2017-2028)
  • 北米のトゥレット症候群治療 市場規模:国別
    • 北米のトゥレット症候群治療 市場規模:国別 (2017-2022)
    • 北米のトゥレット症候群治療 市場規模:国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のトゥレット症候群治療 市場規模 (2017-2028)
  • 欧州のトゥレット症候群治療 市場規模:タイプ別
    • 欧州のトゥレット症候群治療 市場規模:タイプ別 (2017-2022)
    • 欧州のトゥレット症候群治療 市場規模:タイプ別 (2023-2028)
    • 欧州のトゥレット症候群治療の市場シェア:タイプ別 (2017-2028)
  • 欧州のトゥレット症候群治療 市場規模:アプリケーション別
    • 欧州のトゥレット症候群治療 市場規模:アプリケーション別 (2017-2022)
    • 欧州のトゥレット症候群治療 市場規模:アプリケーション別 (2023-2028)
    • 欧州のトゥレット症候群治療の市場シェア:アプリケーション別 (2017-2028)
  • 欧州のトゥレット症候群治療 市場規模:国別
    • 欧州のトゥレット症候群治療 市場規模:国別 (2017-2022)
    • 欧州のトゥレット症候群治療 市場規模:国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 トゥレット症候群治療 市場規模 (2017-2028)
  • アジア太平洋地域 トゥレット症候群治療 市場規模:タイプ別
    • アジア太平洋地域 トゥレット症候群治療 市場規模:タイプ別 (2017-2022)
    • アジア太平洋地域 トゥレット症候群治療 市場規模:タイプ別 (2023-2028)
    • アジア太平洋地域 トゥレット症候群治療の市場シェア:タイプ別 (2017-2028)
  • アジア太平洋地域 トゥレット症候群治療 市場規模:アプリケーション別
    • アジア太平洋地域 トゥレット症候群治療 市場規模:アプリケーション別 (2017-2022)
    • アジア太平洋地域 トゥレット症候群治療 市場規模:アプリケーション別 (2023-2028)
    • アジア太平洋地域 トゥレット症候群治療の市場シェア:アプリケーション別 (2017-2028)
  • アジア太平洋地域 トゥレット症候群治療 市場規模:地域別
    • アジア太平洋地域 トゥレット症候群治療 市場規模:地域別 (2017-2022)
    • アジア太平洋地域 トゥレット症候群治療 市場規模:地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカのトゥレット症候群治療 市場規模 (2017-2028)
  • ラテンアメリカのトゥレット症候群治療 市場規模:タイプ別
    • ラテンアメリカのトゥレット症候群治療 市場規模:タイプ別 (2017-2022)
    • ラテンアメリカのトゥレット症候群治療 市場規模:タイプ別 (2023-2028)
    • ラテンアメリカのトゥレット症候群治療の市場シェア:タイプ別 (2017-2028)
  • ラテンアメリカのトゥレット症候群治療 市場規模:アプリケーション別
    • ラテンアメリカのトゥレット症候群治療 市場規模:アプリケーション別 (2017-2022)
    • ラテンアメリカのトゥレット症候群治療 市場規模:アプリケーション別 (2023-2028)
    • ラテンアメリカのトゥレット症候群治療の市場シェア:アプリケーション別 (2017-2028)
  • ラテンアメリカのトゥレット症候群治療 市場規模:国別
    • ラテンアメリカのトゥレット症候群治療 市場規模:国別 (2017-2022)
    • ラテンアメリカのトゥレット症候群治療 市場規模:国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのトゥレット症候群治療 市場規模 (2017-2028)
  • 中東・アフリカのトゥレット症候群治療 市場規模:タイプ別
    • 中東・アフリカのトゥレット症候群治療 市場規模:タイプ別 (2017-2022)
    • 中東・アフリカのトゥレット症候群治療 市場規模:タイプ別 (2023-2028)
    • 中東・アフリカのトゥレット症候群治療の市場シェア:タイプ別 (2017-2028)
  • 中東・アフリカのトゥレット症候群治療 市場規模:アプリケーション別
    • 中東・アフリカのトゥレット症候群治療 市場規模:アプリケーション別 (2017-2022)
    • 中東・アフリカのトゥレット症候群治療 市場規模:アプリケーション別 (2023-2028)
    • 中東・アフリカのトゥレット症候群治療の市場シェア:アプリケーション別 (2017-2028)
  • 中東・アフリカのトゥレット症候群治療 市場規模:国別
    • 中東・アフリカのトゥレット症候群治療 市場規模:国別 (2017-2022)
    • 中東・アフリカのトゥレット症候群治療 市場規模:国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Co.
  • Mylan NV
  • Otsuka Holdings Co. Ltd.
  • Sanofi S.A.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd
  • Neurocrine Biosciences, Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Tourette Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Antipsychotics
  • Table 3. Key Players of Non Antipsychotics
  • Table 4. Global Tourette Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Tourette Syndrome Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Tourette Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Tourette Syndrome Treatment Market Share by Region (2017-2022)
  • Table 8. Global Tourette Syndrome Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Tourette Syndrome Treatment Market Share by Region (2023-2028)
  • Table 10. Tourette Syndrome Treatment Market Trends
  • Table 11. Tourette Syndrome Treatment Market Drivers
  • Table 12. Tourette Syndrome Treatment Market Challenges
  • Table 13. Tourette Syndrome Treatment Market Restraints
  • Table 14. Global Tourette Syndrome Treatment Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Tourette Syndrome Treatment Revenue Share by Players (2017-2022)
  • Table 16. Global Top Tourette Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Treatment as of 2021)
  • Table 17. Ranking of Global Top Tourette Syndrome Treatment Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Tourette Syndrome Treatment Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Tourette Syndrome Treatment Product Solution and Service
  • Table 21. Date of Enter into Tourette Syndrome Treatment Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Tourette Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Tourette Syndrome Treatment Revenue Market Share by Type (2017-2022)
  • Table 25. Global Tourette Syndrome Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Tourette Syndrome Treatment Revenue Market Share by Type (2023-2028)
  • Table 27. Global Tourette Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Tourette Syndrome Treatment Revenue Share by Application (2017-2022)
  • Table 29. Global Tourette Syndrome Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Tourette Syndrome Treatment Revenue Share by Application (2023-2028)
  • Table 31. North America Tourette Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Tourette Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Tourette Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Tourette Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Tourette Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Tourette Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Tourette Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Tourette Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Tourette Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Tourette Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Tourette Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Tourette Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Tourette Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Tourette Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Tourette Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Tourette Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Tourette Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Tourette Syndrome Treatment Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Tourette Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Tourette Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Tourette Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Tourette Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Tourette Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Tourette Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Tourette Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Tourette Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Tourette Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Tourette Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Tourette Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Tourette Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. AstraZeneca Company Details
  • Table 62. AstraZeneca Business Overview
  • Table 63. AstraZeneca Tourette Syndrome Treatment Product
  • Table 64. AstraZeneca Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 65. AstraZeneca Recent Developments
  • Table 66. Boehringer Ingelheim International GmbH Company Details
  • Table 67. Boehringer Ingelheim International GmbH Business Overview
  • Table 68. Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Product
  • Table 69. Boehringer Ingelheim International GmbH Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 70. Boehringer Ingelheim International GmbH Recent Developments
  • Table 71. Eli Lilly and Co. Company Details
  • Table 72. Eli Lilly and Co. Business Overview
  • Table 73. Eli Lilly and Co. Tourette Syndrome Treatment Product
  • Table 74. Eli Lilly and Co. Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 75. Eli Lilly and Co. Recent Developments
  • Table 76. Mylan NV Company Details
  • Table 77. Mylan NV Business Overview
  • Table 78. Mylan NV Tourette Syndrome Treatment Product
  • Table 79. Mylan NV Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 80. Mylan NV Recent Developments
  • Table 81. Otsuka Holdings Co. Ltd. Company Details
  • Table 82. Otsuka Holdings Co. Ltd. Business Overview
  • Table 83. Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Product
  • Table 84. Otsuka Holdings Co. Ltd. Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 85. Otsuka Holdings Co. Ltd. Recent Developments
  • Table 86. Sanofi S.A. Company Details
  • Table 87. Sanofi S.A. Business Overview
  • Table 88. Sanofi S.A. Tourette Syndrome Treatment Product
  • Table 89. Sanofi S.A. Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 90. Sanofi S.A. Recent Developments
  • Table 91. Pfizer Inc. Company Details
  • Table 92. Pfizer Inc. Business Overview
  • Table 93. Pfizer Inc. Tourette Syndrome Treatment Product
  • Table 94. Pfizer Inc. Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 95. Pfizer Inc. Recent Developments
  • Table 96. Sun Pharmaceutical Industries Ltd Company Details
  • Table 97. Sun Pharmaceutical Industries Ltd Business Overview
  • Table 98. Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Product
  • Table 99. Sun Pharmaceutical Industries Ltd Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 100. Sun Pharmaceutical Industries Ltd Recent Developments
  • Table 101. Neurocrine Biosciences, Inc. Company Details
  • Table 102. Neurocrine Biosciences, Inc. Business Overview
  • Table 103. Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Product
  • Table 104. Neurocrine Biosciences, Inc. Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 105. Neurocrine Biosciences, Inc. Recent Developments
  • Table 106. Novartis AG Company Details
  • Table 107. Novartis AG Business Overview
  • Table 108. Novartis AG Tourette Syndrome Treatment Product
  • Table 109. Novartis AG Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 110. Novartis AG Recent Developments
  • Table 111. Teva Pharmaceutical Industries Ltd. Company Details
  • Table 112. Teva Pharmaceutical Industries Ltd. Business Overview
  • Table 113. Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Product
  • Table 114. Teva Pharmaceutical Industries Ltd. Revenue in Tourette Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 115. Teva Pharmaceutical Industries Ltd. Recent Developments
  • Table 116. Research Programs/Design for This Report
  • Table 117. Key Data Information from Secondary Sources
  • Table 118. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Tourette Syndrome Treatment Market Share by Type: 2021 VS 2028
  • Figure 2. Antipsychotics Features
  • Figure 3. Non Antipsychotics Features
  • Figure 4. Global Tourette Syndrome Treatment Market Share by Application: 2021 VS 2028
  • Figure 5. Children Case Studies
  • Figure 6. Adult Case Studies
  • Figure 7. Tourette Syndrome Treatment Report Years Considered
  • Figure 8. Global Tourette Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 9. Global Tourette Syndrome Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 10. Global Tourette Syndrome Treatment Market Share by Region: 2021 VS 2028
  • Figure 11. Global Tourette Syndrome Treatment Market Share by Players in 2021
  • Figure 12. Global Top Tourette Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Treatment as of 2021)
  • Figure 13. The Top 10 and 5 Players Market Share by Tourette Syndrome Treatment Revenue in 2021
  • Figure 14. North America Tourette Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 15. North America Tourette Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 16. North America Tourette Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 17. North America Tourette Syndrome Treatment Market Size Share by Country (2017-2028)
  • Figure 18. United States Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 19. Canada Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Europe Tourette Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 21. Europe Tourette Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 22. Europe Tourette Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 23. Europe Tourette Syndrome Treatment Market Size Share by Country (2017-2028)
  • Figure 24. Germany Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. France Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. U.K. Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. Italy Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Russia Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Nordic Countries Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Asia-Pacific Tourette Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 31. Asia Pacific Tourette Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 32. Asia Pacific Tourette Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 33. Asia Pacific Tourette Syndrome Treatment Market Size Share by Region (2017-2028)
  • Figure 34. China Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Japan Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. South Korea Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Southeast Asia Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. India Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Australia Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 40. Latin America Tourette Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 41. Latin America Tourette Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 42. Latin America Tourette Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 43. Latin America Tourette Syndrome Treatment Market Size Share by Country (2017-2028)
  • Figure 44. Mexico Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. Brazil Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Middle East & Africa Tourette Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 47. Middle East and Africa Tourette Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 48. Middle East and Africa Tourette Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 49. Middle East and Africa Tourette Syndrome Treatment Market Size Share by Country (2017-2028)
  • Figure 50. Turkey Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 51. Saudi Arabia Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. UAE Tourette Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. AstraZeneca Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 54. Boehringer Ingelheim International GmbH Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 55. Eli Lilly and Co. Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 56. Mylan NV Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 57. Otsuka Holdings Co. Ltd. Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 58. Sanofi S.A. Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 59. Pfizer Inc. Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 60. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 61. Neurocrine Biosciences, Inc. Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 62. Novartis AG Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Tourette Syndrome Treatment Business (2017-2022)
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed
目次

This research report focuses on the Tourette Syndrome Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Tourette Syndrome Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Antipsychotics
    • 1.2.3 Non Antipsychotics
  • 1.3 Market by Application
    • 1.3.1 Global Tourette Syndrome Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Children
    • 1.3.3 Adult
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Tourette Syndrome Treatment Market Perspective (2017-2028)
  • 2.2 Tourette Syndrome Treatment Growth Trends by Region
    • 2.2.1 Tourette Syndrome Treatment Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Tourette Syndrome Treatment Historic Market Size by Region (2017-2022)
    • 2.2.3 Tourette Syndrome Treatment Forecasted Market Size by Region (2023-2028)
  • 2.3 Tourette Syndrome Treatment Market Dynamics
    • 2.3.1 Tourette Syndrome Treatment Industry Trends
    • 2.3.2 Tourette Syndrome Treatment Market Drivers
    • 2.3.3 Tourette Syndrome Treatment Market Challenges
    • 2.3.4 Tourette Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Tourette Syndrome Treatment Players by Revenue
    • 3.1.1 Global Top Tourette Syndrome Treatment Players by Revenue (2017-2022)
    • 3.1.2 Global Tourette Syndrome Treatment Revenue Market Share by Players (2017-2022)
  • 3.2 Global Tourette Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Tourette Syndrome Treatment Revenue
  • 3.4 Global Tourette Syndrome Treatment Market Concentration Ratio
    • 3.4.1 Global Tourette Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Tourette Syndrome Treatment Revenue in 2021
  • 3.5 Tourette Syndrome Treatment Key Players Head office and Area Served
  • 3.6 Key Players Tourette Syndrome Treatment Product Solution and Service
  • 3.7 Date of Enter into Tourette Syndrome Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Tourette Syndrome Treatment Breakdown Data by Type

  • 4.1 Global Tourette Syndrome Treatment Historic Market Size by Type (2017-2022)
  • 4.2 Global Tourette Syndrome Treatment Forecasted Market Size by Type (2023-2028)

5 Tourette Syndrome Treatment Breakdown Data by Application

  • 5.1 Global Tourette Syndrome Treatment Historic Market Size by Application (2017-2022)
  • 5.2 Global Tourette Syndrome Treatment Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Tourette Syndrome Treatment Market Size (2017-2028)
  • 6.2 North America Tourette Syndrome Treatment Market Size by Type
    • 6.2.1 North America Tourette Syndrome Treatment Market Size by Type (2017-2022)
    • 6.2.2 North America Tourette Syndrome Treatment Market Size by Type (2023-2028)
    • 6.2.3 North America Tourette Syndrome Treatment Market Share by Type (2017-2028)
  • 6.3 North America Tourette Syndrome Treatment Market Size by Application
    • 6.3.1 North America Tourette Syndrome Treatment Market Size by Application (2017-2022)
    • 6.3.2 North America Tourette Syndrome Treatment Market Size by Application (2023-2028)
    • 6.3.3 North America Tourette Syndrome Treatment Market Share by Application (2017-2028)
  • 6.4 North America Tourette Syndrome Treatment Market Size by Country
    • 6.4.1 North America Tourette Syndrome Treatment Market Size by Country (2017-2022)
    • 6.4.2 North America Tourette Syndrome Treatment Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Tourette Syndrome Treatment Market Size (2017-2028)
  • 7.2 Europe Tourette Syndrome Treatment Market Size by Type
    • 7.2.1 Europe Tourette Syndrome Treatment Market Size by Type (2017-2022)
    • 7.2.2 Europe Tourette Syndrome Treatment Market Size by Type (2023-2028)
    • 7.2.3 Europe Tourette Syndrome Treatment Market Share by Type (2017-2028)
  • 7.3 Europe Tourette Syndrome Treatment Market Size by Application
    • 7.3.1 Europe Tourette Syndrome Treatment Market Size by Application (2017-2022)
    • 7.3.2 Europe Tourette Syndrome Treatment Market Size by Application (2023-2028)
    • 7.3.3 Europe Tourette Syndrome Treatment Market Share by Application (2017-2028)
  • 7.4 Europe Tourette Syndrome Treatment Market Size by Country
    • 7.4.1 Europe Tourette Syndrome Treatment Market Size by Country (2017-2022)
    • 7.4.2 Europe Tourette Syndrome Treatment Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Tourette Syndrome Treatment Market Size (2017-2028)
  • 8.2 Asia-Pacific Tourette Syndrome Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Tourette Syndrome Treatment Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Tourette Syndrome Treatment Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Tourette Syndrome Treatment Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Tourette Syndrome Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Tourette Syndrome Treatment Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Tourette Syndrome Treatment Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Tourette Syndrome Treatment Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Tourette Syndrome Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Tourette Syndrome Treatment Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Tourette Syndrome Treatment Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Tourette Syndrome Treatment Market Size (2017-2028)
  • 9.2 Latin America Tourette Syndrome Treatment Market Size by Type
    • 9.2.1 Latin America Tourette Syndrome Treatment Market Size by Type (2017-2022)
    • 9.2.2 Latin America Tourette Syndrome Treatment Market Size by Type (2023-2028)
    • 9.2.3 Latin America Tourette Syndrome Treatment Market Share by Type (2017-2028)
  • 9.3 Latin America Tourette Syndrome Treatment Market Size by Application
    • 9.3.1 Latin America Tourette Syndrome Treatment Market Size by Application (2017-2022)
    • 9.3.2 Latin America Tourette Syndrome Treatment Market Size by Application (2023-2028)
    • 9.3.3 Latin America Tourette Syndrome Treatment Market Share by Application (2017-2028)
  • 9.4 Latin America Tourette Syndrome Treatment Market Size by Country
    • 9.4.1 Latin America Tourette Syndrome Treatment Market Size by Country (2017-2022)
    • 9.4.2 Latin America Tourette Syndrome Treatment Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Tourette Syndrome Treatment Market Size (2017-2028)
  • 10.2 Middle East & Africa Tourette Syndrome Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Tourette Syndrome Treatment Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Tourette Syndrome Treatment Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Tourette Syndrome Treatment Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Tourette Syndrome Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Tourette Syndrome Treatment Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Tourette Syndrome Treatment Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Tourette Syndrome Treatment Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Tourette Syndrome Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Tourette Syndrome Treatment Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Tourette Syndrome Treatment Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Company Details
    • 11.1.2 AstraZeneca Business Overview
    • 11.1.3 AstraZeneca Tourette Syndrome Treatment Introduction
    • 11.1.4 AstraZeneca Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.1.5 AstraZeneca Recent Developments
  • 11.2 Boehringer Ingelheim International GmbH
    • 11.2.1 Boehringer Ingelheim International GmbH Company Details
    • 11.2.2 Boehringer Ingelheim International GmbH Business Overview
    • 11.2.3 Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Introduction
    • 11.2.4 Boehringer Ingelheim International GmbH Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.2.5 Boehringer Ingelheim International GmbH Recent Developments
  • 11.3 Eli Lilly and Co.
    • 11.3.1 Eli Lilly and Co. Company Details
    • 11.3.2 Eli Lilly and Co. Business Overview
    • 11.3.3 Eli Lilly and Co. Tourette Syndrome Treatment Introduction
    • 11.3.4 Eli Lilly and Co. Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.3.5 Eli Lilly and Co. Recent Developments
  • 11.4 Mylan NV
    • 11.4.1 Mylan NV Company Details
    • 11.4.2 Mylan NV Business Overview
    • 11.4.3 Mylan NV Tourette Syndrome Treatment Introduction
    • 11.4.4 Mylan NV Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.4.5 Mylan NV Recent Developments
  • 11.5 Otsuka Holdings Co. Ltd.
    • 11.5.1 Otsuka Holdings Co. Ltd. Company Details
    • 11.5.2 Otsuka Holdings Co. Ltd. Business Overview
    • 11.5.3 Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Introduction
    • 11.5.4 Otsuka Holdings Co. Ltd. Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.5.5 Otsuka Holdings Co. Ltd. Recent Developments
  • 11.6 Sanofi S.A.
    • 11.6.1 Sanofi S.A. Company Details
    • 11.6.2 Sanofi S.A. Business Overview
    • 11.6.3 Sanofi S.A. Tourette Syndrome Treatment Introduction
    • 11.6.4 Sanofi S.A. Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.6.5 Sanofi S.A. Recent Developments
  • 11.7 Pfizer Inc.
    • 11.7.1 Pfizer Inc. Company Details
    • 11.7.2 Pfizer Inc. Business Overview
    • 11.7.3 Pfizer Inc. Tourette Syndrome Treatment Introduction
    • 11.7.4 Pfizer Inc. Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.7.5 Pfizer Inc. Recent Developments
  • 11.8 Sun Pharmaceutical Industries Ltd
    • 11.8.1 Sun Pharmaceutical Industries Ltd Company Details
    • 11.8.2 Sun Pharmaceutical Industries Ltd Business Overview
    • 11.8.3 Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Introduction
    • 11.8.4 Sun Pharmaceutical Industries Ltd Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.8.5 Sun Pharmaceutical Industries Ltd Recent Developments
  • 11.9 Neurocrine Biosciences, Inc.
    • 11.9.1 Neurocrine Biosciences, Inc. Company Details
    • 11.9.2 Neurocrine Biosciences, Inc. Business Overview
    • 11.9.3 Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Introduction
    • 11.9.4 Neurocrine Biosciences, Inc. Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.9.5 Neurocrine Biosciences, Inc. Recent Developments
  • 11.10 Novartis AG
    • 11.10.1 Novartis AG Company Details
    • 11.10.2 Novartis AG Business Overview
    • 11.10.3 Novartis AG Tourette Syndrome Treatment Introduction
    • 11.10.4 Novartis AG Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.10.5 Novartis AG Recent Developments
  • 11.11 Teva Pharmaceutical Industries Ltd.
    • 11.11.1 Teva Pharmaceutical Industries Ltd. Company Details
    • 11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
    • 11.11.3 Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Introduction
    • 11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Tourette Syndrome Treatment Business (2017-2022)
    • 11.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer